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Abstract
Devrieseasis caused by Devriesea agamarum is a highly prevalent disease in
captive desert lizards, resulting in severe dermatitis and in some cases mass
mortality. In this study, we assessed the contribution of autovaccination to
devrieseasis control by evaluating the capacity of 5 different formalin-inactivated D.
agamarum vaccines to induce a humoral immune response in bearded dragons
(Pogona vitticeps). Each vaccine contained one of the following adjuvants: CpG,
incomplete Freund’s, Ribi, aluminium hydroxide, or curdlan. Lizards were
administrated one of the vaccines through subcutaneous injection and booster
vaccination was given 3 weeks after primo-vaccination. An indirect ELISA was
developed and used to monitor lizard serological responses. Localized adverse
effects following subcutaneous immunization were observed in all but the Ribi
adjuvanted vaccine group. Following homologous experimental challenge, the
incomplete Freund’s as well as the Ribi vaccine were observed to confer protection
in bearded dragons against the development of D. agamarum associated
septicemia but not against dermatitis. Subsequently, two-dimensional
gelelectrophoresis followed by immunoblotting and mass spectrometry was
conducted with serum obtained from 3 lizards that showed seroconversion after
immunisation with the Ribi vaccine. Fructose-bisphosphate aldolase and aldo-keto
reductase of D. agamarum reacted with serum from the latter lizards. Based on the
demonstrated seroconversion and partial protection against D. agamarum
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associated disease following the use of formalin-inactivated vaccines as well as the
identification of target antigens in Ribi vaccinated bearded dragons, this study
provides promising information towards the development of a vaccination strategy
to control devrieseasis in captive lizard collections.
Introduction
Devriesea agamarum is the causative agent of chronic proliferative dermatitis and
septicemia in several genera of desert-dwelling lizards [1, 2, 3]. D. agamarum
related disease appears to be highly contagious and may affect a complete lizard
collection within several months [1, 4]. While in dab lizards (Uromastyx species)
mortality remains low despite high morbidity, considerable mortality occurs in
other agamid and iguanid species [3]. Recently, D. agamarum was shown to be
able to persist for several years in captive lizard colonies [5]. Persistence is
promoted by prolonged environmental survival of the bacterium as well as the
existence of asymptomatic carriers, which form a major reservoir for D.
agamarum infection [1, 5, 6]. Successful antimicrobial treatment and efficient
disinfection procedures have previously been established to control D. agamarum
associated disease [2, 6]. Besides quarantine and entry control of newly acquired
lizards [4], other preventive measures against D. agamarum associated disease in
captive lizard collections, do not exist. Prophylactic immunization of lizards could
offer a powerful tool to prevent introduction or spread of the disease into captive
collections and/or to reduce the severity of infection.
Like all jawed vertebrates, reptiles have both an innate and adaptive immune
system [7]. Nevertheless, immune function of reptiles has received relatively
minor attention and little is known concerning the existence of affinity
maturation in lizards and other reptiles [8, 9]. More than in other vertebrates, the
immune response in these ectothermic amniotes is influenced by a variety of
environmental as well as seemingly species dependent factors [7]. Moreover,
differences in antigen properties and route of antigen uptake account for highly
variable immune responses in lizards [10]. Presently, there are only two
documented examples of challenge/vaccination experiments in reptiles [8, 9].
The purpose of the present study was to determine the effect of prophylactic
immunization of bearded dragons (Pogona vitticeps) against the D. agamarum
type strain. First, the development of a humoral immune response was assessed
following the administration of 5 different formalin-inactivated D. agamarum
vaccines in bearded dragons. Next, the most suitable vaccine formulations were
selected to conduct challenge/vaccination experiments. Finally, the target antigens
of the induced antibodies were identified.
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Materials and Methods
Preparation of a formalin-killed Devriesea agamarum suspension
and challenge inoculum
The type strain of D. agamarum (5LMG 24257T5IMP 2) was used to prepare
bacterial suspensions for immunization, experimental inoculation and western
blotting. Suspensions were prepared after incubation of D. agamarum on
Columbia agar with 5% sheep blood (COL, Oxoid GmbH, Wesel, Germany)
during 24 h at 37 C˚ and 5% CO2.
For vaccine preparation, ten D. agamarum colonies were transferred to 100 ml
of Columbia broth and incubated during 24 h at 37 C˚ and 5% CO2. A 10-ml
aliquot was taken from the broth, pelleted by centrifugation (3000 rpm,
10 minutes, 4 C˚) and suspended in phosphate buffered saline (PBS).
Subsequently, the number of colony-forming units (cfu) was determined by
plating serial tenfold dilutions on COL agar. The suspension had an optic density
of 1.560, which equalled 109 cfu/ml. Next, the broth was supplemented with 36%
formalin to a final concentration of 0.5% and incubated overnight at 37 C˚. After
centrifugation (5000 rpm, 30 minutes, room temperature), bacteria were
suspended in PBS. To confirm complete killing, 50-ml aliquots of the bacterial
suspension were plated onto COL agar, incubated at 37 C˚ and 5% CO2 during
48 h.
To prepare the challenge inoculum, 10 colonies were harvested and incubated
during 24 h in 5 ml of brain heart infusion (BHI, Merck, Darmstadt, Germany)
broth at 37 C˚ and 5% CO2. Following centrifugation (3000 rpm, 10 minutes, 4 C˚)
the bacteria were washed three times in 5 ml of phosphate buffered saline (PBS).
The inoculum was diluted with PBS to an optic density of 1.050, which equaled
108 cfu/ml.
ELISA for the evaluation of the antibody response against the
Devriesea agamarum type strain
An indirect ELISA was developed to assess the antibody response in bearded
dragons (P. vitticeps) following immunization against D. agamarum. All
experiments were performed with the permission of the Ethical Committee of the
Faculty of Veterinary Medicine, Merelbeke, Ghent University, Belgium (author-
ization number 2009_071 and 2009_089). During all experiments lizards were
housed individually in a room where the temperature was maintained at 28 C˚
during the day and 20 C˚ during the night. A 12-hour photoperiod was given with
a self-ballasted bulb installed above each enclosure, creating a local hot spot.
Rabbit sera
Anti-lizard immunoglobulin serum was prepared in rabbits after immunization
with lizard immunoglobulins. Immunoglobulins were collected from lizard serum
obtained from healthy, adult P. vitticeps using the ammonium precipitation
method and subsequent dialysis, as previously described by Pasmans et al. [11].
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Rabbits were immunized with 1 mg of the purified protein fraction in 1 ml of
50% incomplete Freund’s adjuvant (Sigma-Aldrich, Bornem, Belgium).
Subsequent immunizations were administered on days 14 and 28. Rabbits were
anesthetized and exsanguinated on day 42. Plasma was separated and stored at
270 C˚.
Serological response of bearded dragons (Pogona vitticeps) immunized with 5
different inactivated Devriesea agamarum vaccines
Twenty-five clinically healthy 1.5-year-old bearded dragons, weighing 140 to
190 g, were immunized with the formalin-inactivated D. agamarum type strain.
All products were purchased from Sigma-Aldrich, Bornem, Belgium unless stated
otherwise. Five groups of 5 lizards each received one of the following vaccines,
each containing a total of 16108 cfu, through subcutaneous injection at the
dorsolateral skin region: 1) 100 ml of 30% CpG vaccine (CpG oligodeoxynu-
cleotide, Biosource, Nivelles, Belgium), 2) 200 ml of 50% incomplete Freund’s
adjuvant vaccine, 3) 100 ml vaccine suspension emulsified in Ribi adjuvant (50 mg
monophosphoryl lipid A plus 50 mg synthetic trehalose dimycolate), 4) 200 ml of
50% aluminium hydroxide vaccine, and 5) 100 ml of 30% curdlan vaccine.
Preimmune heparinized blood samples were collected prior to primo-vaccination.
Subsequently, blood was collected weekly during 7 weeks and booster vaccination
was given after 21 days. All bearded dragons were examined daily for the
development of adverse effects following immunization. Signs of generalized
effects such as anorexia and apathy or localized skin alterations at the site of
injection such as skin discoloration or the development of dermal inflammation,
were closely monitored in all immunized lizards during a 100 days observation
period.
ELISA procedure
Wells of 96-well microtiter plates (Maxisorp, Nunc, Roskilde, Denmark) were
coated with 150 ml of a formalin-inactivated D. agamarum suspension of
76107 cfu/ml in 0.05 M carbonate-bicarbonate buffer (pH 9.6) and incubated
for 24 h at 4 C˚. The plates were washed 4 times with PBS supplemented with
0.05% Tween 20 (washing buffer), dried and stored at 4 C˚. Between each
incubation step, the wells were washed 5 times. Lizard sera were diluted 1:64 in
washing buffer with 2.2% skim milk powder. Preimmune as well as immune
serum samples from individual lizards were analysed in 3-fold and incubated on
the same antigen coated plate in order to minimize variability of demonstrated
OD values resulting from differences in coating and further processing of the
plates. One-hundred microliters of diluted lizard serum samples were added to
each well and the plates were incubated for 2 h at 37 C˚. Subsequently, the wells
were incubated with 100 ml of rabbit anti-lizard serum, diluted 1:7000 in washing
buffer with 2.2% skim milk powder, for 2 h at 37 C˚. Then, 100 ml of goat anti-
rabbit immunoglobulin G labeled with horseradish peroxidase (Sigma-Aldrich)
was applied at a dilution of 1:1000 in washing buffer with 2.2% skim milk powder
and incubated for 30 min at 37 C˚. Finally, citric acid buffer 0.04 M (pH 5.0) in
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phosphate buffer with 0.07% orthophenylene diamine (Sigma-Aldrich) and
0.22% hydrogen peroxide were added in 100 ml volumes per well. The reaction
was halted after 10 min by adding 50 ml of 2.5 M hydrochloric acid. Absorbancies
were read at 492 nm on an ELISA reader (Titertek, Helsinki, Finland).
Challenge/vaccination experiments in bearded dragons
(Pogona vitticeps)
A total of twenty-two clinically healthy 8-month-old bearded dragons, weighing
80 to 120 g, were used. A first group of five bearded dragons and a second group
of six lizards received 200 ml of the incomplete Freund’s adjuvant and 100 ml of
the Ribi adjuvanted vaccine, respectively. Both vaccines contained 16108 cfu and
were administered through subcutaneous injection at the dorsolateral skin region.
Vaccine administration was repeated after 3 weeks. The remaining lizards were
injected subcutaneously with saline. A blood sample was collected from each
lizard prior to first immunization and subsequently prior to the experimental
inoculation. The latter was performed 2 weeks after the booster immunization, by
infiltrating the dorsolateral skin of the lizards with a bacterial inoculum in order
to induce D. agamarum associated dermatitis and/or septicemia. Therefore, the
skin of all lizards was infiltrated with 600 ml of a D. agamarum suspension
containing 36108 cfu, using a 26 Gauge needle following local disinfection with
ethanol as described by Hellebuyck et al. [1, 2]. All lizards were evaluated twice
daily for clinical signs related to the development of dermatitis and/or septicemia.
Upon development of macroscopic dermatitis, sampling for the presence of D.
agamarum was performed every 2 days. Lizards showing signs indicative for
septicemia, such as anorexia, severe depression and diffuse dark discoloration of
the skin, were euthanized out of ethical considerations and necropsy was
performed.
Immunoproteomics
Devriesea agamarum cellysate
A few colonies of the D. agamarum suspension were transferred to 5 ml Luria
Broth (LB, Sigma-Aldrich, St. Louis, USA) and incubated at 37 C˚ for 24 h, while
shaking. Subsequently, 45 ml LB was added for another incubation of 24 h.
After incubation, the D. agamarum bacteria were washed with HBBS and
proteins were extracted by means of the ReadyPrep Sequential Extraction Kit
(Bio-Rad, Hercules, CA, USA) according to manufacturer’s instructions. The
extraction buffer was supplemented with tributylphosphine (Biorad), protease
inhibitors cocktail (Amersham-GE Healthcare, New Jersey, USA), DNAse and
phosphatase inhibitors PP2 and PP3 (Sigma-Aldrich, Steinheim, Germany).
Protein quantification was determined by Bradford Coomassie assay.
Two-dimensional gelelectrophoresis
One hundred micrograms of lysate were separated in two dimensions as
previously described [12]. In short, proteins were solubilized in rehydration buffer
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(7 M urea, 2 M thiourea, 2% CHAPS, 0.2% carrier ampholytes, 100 mM DTT,
bromophenolblue), rehydrated in a Readystrip IPG strip (pI 4–7) (Bio-Rad) and
separated according to their iso-electric point in a Protean IEF Cell (Biorad).
Subsequently, the strips were incubated in 1.5% DTT and in 4% iodoacetamide
and during 10 minutes in equilibrationbuffer (50 mM Tris-HCl pH 8.8, 6 M
urea, 20% glycerol, 2% SDS). Separation based on molecular weight was
performed on a 10% Tris HCl gel at 150 V for 30 minutes, followed by 200 V for
1 hour. Proteins were visualized with Sypro Ruby staining after fixation in 10%
MeOH and 7% acetic acid for at least 30 minutes.
Immunodetection
Proteins from the gel were transferred onto a nitrocellulose membrane in a Trans-
blot cell filled with 0.1 M CAPS (pH511) at 50 V for 30 minutes. Successful
transfer was checked with Ponceau S staining. First, the blots were blocked with
0.3% Tween 20 in PBS for minimum 1 hour and then incubated overnight with
the primary antibody (pre- and post-immune sera; 1:100 in blocking buffer). After
3 washing steps (365 minutes 0.3% Tw20 in PBS), secondary antibody was
applied on the blots for 1 hour (rabbit anti-lizard antibodies, 1:1000 in blocking
solution). Finally, again after 3 washing steps, the blot was incubated with tertiary
antibody (goat anti-rabbit HRP-labeled antibodies, 1:20000 in blocking buffer)
followed by chemiluminescence detection.
Protein identification
Immunoreactive spots on western blot were matched with their accompanying
Sypro stained gel and the immunoreactive proteins were excised from the gel.
Peptides were extracted after in gel digestion. Gel pieces were washed twice for
10 minutes in wash solution (25 mM ammonium bicarbonate (ABC); 50%
acetonitrile (ACN)), reduced for 10 minutes at 56 C˚ in 100 mL of 10 mM DTT
and 25 mM ABC followed by 20 minutes at room temperature. Alkylation was
performed with 100 mL 100 mM iodoacetamide and 25 mM ABC for 45 minutes
at room temperature. After a washing step, the gel pieces were dehydrated with
100% ACN and modified trypsin (200 ng trypsin in 20 mL ABC, Promega,
Madison, USA) was added for overnight digestion at 37 C˚. Peptides were
extracted in two steps: first by means of 50 mL of 50% ACN followed by 100 mL of
100% ACN.
Dried proteins were dissolved in 0.1% formic acid (FA), separated by liquid
chromatography as previously described [13]. Mass spectrometric analysis was
performed on a ESI Q-TOF Premier (Waters, Milford, MA, USA) in a data
dependent mode, where automatically switching between MS (m/z 425–1200) and
MS/MS (m/z 50–2100) occurred on up to seven higher charge ions, when the
intensity of the individual ions rose above 60 counts per second.
Aminoacid sequences were matched by Mascot Daemon using the in-house
sequenced genome from D. agamarum. Identified open reading frames (orf) with
a p-value of minimum 0.05 were subjected to basic local alignment search tool
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(BLAST) for alignment with publicly available 35 203 249 non-redundant protein
sequences (release 131218), using BLASTx program [14].
The GS De Novo Assembler version 2.6 was used to perform a de novo genome
assembly using GS FLX reads. The Illumina mate-paired reads were used to
scaffold the GS De Novo Assembler contigs using SSPACE Basic 2.0 [15]. The
EMBOSS package [16] was used to find orfs with a minimum length of 100 bp in
the scaffolds.
Data analysis
Seroconversion of bearded dragons following vaccination against D. agamarum
was monitored and compared after administering 5 different vaccines, all
containing 16108 CFU, but each assembled with a specific adjuvans. A total of 5
vaccines (5 different adjuvantia) were evaluated by immunization of 5 lizards in
each experimental group. A lizard was considered to have seroconverted if the OD
after immunization reached at least the mean OD value derived from repeated
analyses of individual preimmune serum samples plus 3 times the standard
deviation. By this means the number of seroconverted lizards in each group could
be identified (with a maximum of 5 seroconverted animals).
Due to the limited numbers of animals in each sample group (5 animals in each
group), the Fisher’s Exact test was applied to screen for possible statistical
differences between the use of the different vaccines (i.e. different adjuvantia). The
same test was applied to monitor the effectiveness of the 2 most suitable
D. agamarum vaccines in a challenge/vaccination experiment with 22 lizards.
A statistical difference between groups was assumed if p,0.05 (SPSS statistics
version 22.0, IBM, Belgium).
Results
Immunization of bearded dragons (Pogona vitticeps) against
Devriesea agamarum results in seroconversion
ELISA results
The optical density (OD) values of lizard preimmune serum samples showed
overall high inter-individual variability. Accordingly, cut-off OD values were
calculated for each lizard individually in all experiments as the mean OD value
derived from repeated analyses of individual preimmune serum samples plus 3
times the standard deviation. A lizard was considered to have seroconverted when
OD values higher than this cut-off OD were demonstrated for sera collected after
immunization. OD values were determined in 3-fold for all serum samples
obtained from immunized animals.
During the first experiment, conducted to evaluate the serological response of
bearded dragons after immunization with 5 different D. agamarum vacines,
seroconversion was observed in 2 out of 5 lizards in the groups that were
administrated the CpG vaccine and in 3 out of 5 lizards that were immunized with
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the Ribi or incomplete Freund’s vaccine. All showed seroconversion prior to
booster vaccination except for 2 out of 3 lizards, immunized with the Ribi
adjuvanted vaccine, which seroconverted 1 week after booster vaccination (
Figure 1). In the groups that were vaccinated with the aluminium hydroxide and
curdlan vaccine, seroconversion could not be demonstrated in any of the lizards.
No significant difference in the number of seroconverted lizards could be
observed for the 5 different D. agamarum vaccines (Fisher’s Exact test, p.0.05). A
remarkable trend, however, was observed for both the Ribi and incomplete
Freund’s vaccine, indicating a more successful immunization when compared to
the effect of immunization with the aluminium hydroxide and curdlan vaccine
(Fisher’s Exact test; p50.083).
Following immunization of bearded dragons with the incomplete Freund’s and
Ribi adjuvanted vaccine during the challenge/vaccination experiment, serocon-
version was observed in 1 out of 5 and 2 out of 6 immunized lizards respectively, 5
weeks after primo-vaccination. In none of the sham immunized lizards could
seroconversion be demonstrated. These results could not be proven to be
significantly better to the sham immunization of lizards in which no
seroconversion could be observed (Fisher’s Exact test).
Adverse effects following immunization and challenge
Except for the lizards that received the Ribi adjuvanted vaccine, localized adverse
immunization effects were observed following vaccine administration in all other
groups, consisting of extensive granulomatous inflammation at the immunization
sites (Table 1). Immunization did not seem to elicit generalized adverse effects in
any of the lizards.
Following primo-vaccination with the CpG vaccine, large subcutaneous
nodules with an average size of 1 cm diameter were observed at day 13 in two
lizards. The size of these nodules gradually decreased to 0.5 cm diameter average
at day 70 and remained constant in size during the entire observation period.
Following booster inoculation 3 bearded dragons developed a subcutaneous
nodule of 1 cm diameter at the inoculation site at day 50. These nodules remained
present throughout the entire observation period. In all lizards that received the
incomplete Freund’s vaccine during the first experiment, conducted to compare
the effect of 5 different vaccines, large subcutaneous nodules of 1.5 cm diameter
on average were observed immediately following first immunization. Following
second immunization similar nodular lesions developed in all 5 lizards. In two
lizards the nodules, induced following second immunization decreased gradually
in size from day 60 and disappeared almost completely at the end of the
observation period. All other nodules remained present and did not decrease in
size during the entire observation period.
Immediately following administration of the incomplete Freund’s vaccine
during the challenge/vaccination trial, demarcated nodular lesions of 0.8 cm
diameter on average were observed in all lizards. After the second immunization
identical adverse effects were observed. Although an initial decrease in size to
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0.6 cm on average was noted at day 5, the size of the nodular lesions remained
constant during the rest of the trial.
In the group of lizards that was vaccinated with aluminium hydroxide all
animals developed subcutaneous nodules with an average diameter of 0.75 cm at
day 5 to 13, which resolved in two lizards at day 35 on average and started
decreasing in size from day 50 in the remaining lizards. Following second
immunization identical adverse effects were seen in all lizards at day 30. At the end
of the observation period, all lesions in every lizard had disappeared except for
one lizard.
None of the lizards belonging to the curdlan vaccine group showed local or
generalized adverse effects following first immunization. After second immuni-
zation, however, relatively small nodules were noted in 4 lizards at day 40 with an
average diameter of 0.4 cm. In 4 out of 5 lizards, these lesions almost completely
resolved. In one lizard a small subcutaneous nodule could be observed until the
end of the observation period.
At the end of the observation period of the first experiment, full thickness
biopsies of the subcutaneous nodules were collected in two lizards that were
immunized with the incomplete Freund’s adjuvanted vaccine using a 3 mm
diameter biopsy punch (Paramount Surgimed Ltd., New Dehli, India). Tissues
were fixed in 10% neutral buffered formalin, processed routinely, embedded in
paraffin and stained with hematoxylin and eosin. Histological sections revealed
multifocal subcutaneous granuloma’s of variable size containing few cells. The
Figure 1. Antibody response of bearded dragons (Pogona vitticeps) following immunization against
Devriesea agamarum. Results of ELISA of immune and preimmune (0 weeks) lizard sera at 1:64 dilution
following first immunization at week 0 and booster immunization at week 3 with a formalin-inactivated
Devriesea agamarum vaccine containing (A) CpG adjuvant, (B) incomplete Freund’s adjuvant and (C) Ribi
adjuvant. Each vaccine formulation was administered to 5 lizards and serum was collected weekly during a 7-
week period. A cut-off value was calculated for each lizard individually as the mean OD value derived from
repeated analyses of individual preimmune serum samples plus 3 times the standard deviation. The moment
of seroconversion, defined as the point in time when the demonstrated OD values exceed the cut-off value,
and the corresponding cut-off value is indicated for the individual lizards (arrow).
doi:10.1371/journal.pone.0113084.g001
Table 1. Localized adverse effects in bearded dragons following subcutaneous immunization with various formalin-inactivated Devriesea agamarum
vaccines.
Vaccine Adverse effects
Number of lizards with
adverse effects (n55)
Onset (average time in days following
first immunization)
Maximum size of nodule
(average, cm3)
[1] [2] [1] [2] [1] [2]
CpG Yes 2 3 13 50 1 1
Incomplete Freund’s Yes 5 5 1 21 1.5 1.5
Ribi No - - - - - -
Aluminium hydroxide Yes 5 5 9 30 0.75 0.75
Curdlan Yes 0 4 - 40 - 0.4
[1], [2]: first immunization and second immunization (day 21) respectively.
doi:10.1371/journal.pone.0113084.t001
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granuloma’s consisted of a fibrous capsule surrounding different layers of
macrophages and a central eosinophilic core. In addition, dermal infiltration of
lymphocytes, plasma cells, heterophils and macrophages was observed. The
presence of bacteria within the cytoplasm of the latter macrophages and in the
core of the granuloma’s was confirmed by periodic acid Shiff staining.
Seroconversion following autovaccination against Devriesea
agamarum confers protection against the development of
septicemia but not dermatitis
During the challenge/vaccination experiment, the vaccinated as well as the non-
vaccinated lizards developed dermatitis in the inoculated region of dorsolateral
skin at 5 days on average post inoculation. The dermal lesions evolved to
encrusted, discolored areas of infected skin with purulent discharge.
In the incomplete Freund’s vaccinated group, none of the vaccinated animals
showed obvious clinical signs indicative for septicemia. One of these lizards,
however, showed a 3 day period of anorexia from the 9th until the 11th day post
inoculation. In the Ribi immunized group, 3 lizards showed anorexia from 6 days
post inoculation until the 9th day on average post inoculation. From then on, the
latter bearded dragons seemed fully recovered and remained in a general good
condition throughout the trial.
Eight non-vaccinated lizards showed decreased appetite and demonstrated
other signs suggestive for systemic disease at the 4th day on average post
Figure 2. Sypro-staining of a two-dimensional gel of Devriesea agamarum cellysate. Immunoreactive
spots that emerge after vaccination in at least 2 of the 3 animals (3.2, 3.3, 3.4) were identified by mass
spectrometry. Identification of the marked spots are depicted in table 2.
doi:10.1371/journal.pone.0113084.g002
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inoculation. These clinical signs became progressively worse and consisted of
anorexia, pronounced apathy, diffuse dark discoloration of the skin and
intermittent but severe dyspnea. Five of the latter lizards reached ethical endpoints
and were humanely euthanized at day 9, 10, 12, 13 and 21 post inoculation
respectively. The general condition of the 3 other lizards that displayed signs of
septicemia gradually improved. These animals regained appetite and seemed fully
recovered at day 15 on average post inoculation.
From all lizards D. agamarum could be isolated from the inoculated areas of
skin until the end of the trial. Following necropsy of the 5 euthanized bearded
dragons, D. agamarum was isolated in pure and abundant culture from skin, liver,
spleen and kidney. In 3 of the latter lizards, D. agamarum was additionally
cultured from the bone marrow.
Table 2. Protein identifications with a p-value ,0.05 of immunoreactive spots from Figure 2.
N˚ serum Mass Score Matches Protein name
1 3.3 53531 1022 20 Dihydrolipoamide dehydrogenase
3.4 53531 1205 26 Dihydrolipoamide dehydrogenase
2 3.3 40579 148 5 serine/threonine protein kinase
3.4 40579 345 7 serine/threonine protein kinase
3 3.3 36909 171 4 dTDP-glucose 4,6-dehydratase
3.4 36909 128 3 dTDP-glucose 4,6-dehydratase
4 3.3 33555 228 5 Cysteine synthase
3.4 33555 98 2 Cysteine synthase
5 3.3 40579 92 4 serine/threonine protein kinase
3.4 40579 118 4 serine/threonine protein kinase
6 3.3 31255 521 10 NAD-dependent protein deacetylase, SIR2 family
3.4 31255 632 14 NAD-dependent protein deacetylase, SIR2 family
7 3.3 27611 588 9 Triosephosphate isomerase
19111 254 4 Translation elongation factor Tu
37705 184 3 Fructose-bisphosphate aldolase
3.4 27611 733 13 Triosephosphate isomerase
43870 315 5 Translation elongation factor 1A (EF-1A/EF-Tu)
37705 160 3 Fructose-bisphosphate aldolase
8 3.2 30902 479 10 Putative oxidoreductase
37705 123 2 Fructose-bisphosphate aldolase
3.3 30902 186 5 Aldo/keto reductase, diketogulonate reductase
37705 139 3 Fructose-bisphosphate aldolase
3.4 37705 366 7 Fructose-bisphosphate aldolase
9 3.3 32098 398 6 ATP synthase, F1 delta subunit
3.4 32098 640 9 ATP synthase, F1 delta subunit
N˚ serum: the animal from which this immunoreactive spot was identified; mass: molecular weight of the identified protein; score: score of protein
identification determined by Mascot Daemon; matches: number of peptides identified per open reading frame (orf); protein name: name of the protein after
blasting the identified orf.
doi:10.1371/journal.pone.0113084.t002
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Antigen identification of Ribi vaccine
Sera collected 5 weeks after primo vaccination from the three lizards that showed
seroconversion after Ribi vaccination were used for immunoblotting experiments
(referred to as 3.2, 3.3 and 3.4). Therefore, for each animal 2 western blots with D.
agamarum cell lysates were made, one was incubated with serum before
vaccination and the other with serum after vaccination. Both western blots were
compared to each other. Differential immunoreactive spots on the post-
vaccination blot were matched with their accompanying gel and identified by
means of mass spectrometry. Immunoreactive spots that were present in at least 2
of the 3 animals and which yielded, after excision from their accompanying gel,
the same protein identifications are summarized in figure 2 and table 2.
Serum from animal 3.3 and 3.4 showed reactivity against dihydrolipoamide
dehydrogenase, serine/threonine protein kinase, dTDP-glucose 4,6-dehydratase,
cysteine synthase, triosephosphate isomerase, translation elongation factor Tu,
and ATP synthase, F1 delta subunit. Aldo/keto reductase was identified as
immunoreactive in serum 3.2 and 3.3. Two proteins, fructose-bisphosphate
aldolase and aldo-keto reductase, were found as immunoreactive spot in all 3
animals.
Discussion
Entry control and quarantine of newly acquired lizards, the use of appropriate
disinfection procedures and antimicrobial treatment have previously been
described as essential aspects of an integrated approach to prevent and eliminate
devrieseasis from captive lizard collections [2, 4, 5, 6]. In collections with
persistent and high mortality associated to D. agamarum infection, autovaccina-
tion could serve as an additional powerful and even indispensable tool towards
disease control.
Although generally considered as the serodiagnostic method of choice, indirect
ELISAs require the availability of specific antispecies monoclonal or polyclonal
antibodies [17]. Commercial antibodies for use in serological testing of reptiles are
largely unavailable forcing investigators wishing to work with these types of
reagents to produce their own [17]. The indirect ELISA used in this study was not
developed to design a practical serodiagnostic test to determine exposure of
lizards to D. agamarum, but it did allow the unambiguous detection of
seroconversion in lizards after immunization against D. agamarum. The
development of specific rabbit anti-lizard monoclonal or polyclonal serum after
immunization of rabbits with purified P. vitticeps immunoglobulins could be an
important step to enhance and broaden the applicability of the used indirect
ELISA.
Based on the overall results of this study, there was no evidence for affinity
maturation following the use of the described vaccination protocols against
D. agamarum in bearded dragons. Booster injections of the antigen or
experimental inoculation did not result in an obvious increase of OD values over a
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longer period of time. This finding corresponds with those observed following
immunization of several lizard species with a variety of antigens [18, 19]. An
obvious increase of the affinity of low-molecular-weight antibodies on the other
hand was previously demonstrated in immunized tortoises, several snake species,
alligators and desert iguana’s (Dipsosaurus dorsalis) [18, 20, 21]. In one lizard that
received the Ribi adjuvanted vaccine however, it should be noted that a steady
increase in serum OD values was observed with an additional rise following
booster immunization to reach a peak value 7 weeks following primo-vaccination.
In order to induce a strong antibody response adjuvants are routinely used as
nonspecific stimulators of the immune response [22]. Incomplete Freund’s and
Ribi adjuvant have been previously used in reptile immunization studies and
proved to evoke a strong and prolonged immune response [17, 22, 23]. The use of
incomplete Freund’s adjuvant, however, may result in considerable adverse effects,
mostly presenting as granulomatous inflammatory responses and focal necrosis
[22, 24]. During this study these adverse effects were highly prominent in
incomplete Freund’s vaccinated lizards. In contrast, the newer synthetic adjuvant
Ribi did not elicit adverse effects and induced overall comparable levels of
seroconversion as the incomplete Freund’s adjuvanted vaccine. For this reason the
proteomics research was focused on serum obtained from Ribi vaccinated
animals.
The development of a cell mediated immune response following the use of the
different vaccine formulations against D. agamarum was not investigated during
this study. Antigen specific cell mediated immune responses have been detected in
different reptile species [7, 23] and cell mediated immunity may contribute to the
partial protection following immunization against D. agamarum infection
observed in this study. To assess the overall immune responsiveness in bearded
dragons as a result of immunization against D. agamarum, evaluating the cell
mediated immune and correlating the latter response with the antibody response
would be essential.
As the described immunization with incomplete Freund’s and Ribi vaccine
conferred partial protection against D. agamarum associated disease in lizards,
variation in antigen composition or mode of antigen inactivation, route of
administration and booster interval and frequency should be strongly considered
and may result in a more favorable outcome towards the development of an
immunization protocol aiming to prevent D. agamarum induced dermatitis in
lizards.
Proteomic analysis yielded two D. agamarum antigens that may be interesting
candidates for vaccine development, fructose-bisphosphate aldolase and aldo-keto
reductase. Fructose-bisphophate aldolase is a zinc-binding reversible enzyme in
the glycolysis. It catalyzes the cleavage of fructose-1,6-bisphosphate to
dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate [25]. Aldo-keto
reductase represents a superfamily of soluble NAD(P)(H) oxidoreductases whose
chief purpose is to reduce aldehydes and ketones to primary and secondary
alcohols [26]. However, the protein names are based on blasting since no
annotated sequence database is available for D. agamarum. Proteins that are
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unique to this bacterium will therefore be missed. The latter seemed not the case
since after blasting the identified proteins were all found with high alignment
scores in Brachybacterium species as well, a species closely related to D. agamarum
from which sequenced genes were already annotated [27].
One could wonder whether cytosolic proteins can be involved in establishing an
immune response. Several reports, however, have already stated the transient
presence of cytosolic proteins at the cell surface even without the presence of a
signal peptide [28, 29]. Accordingly, fructose-bisphophate aldolase has already
been detected at the cell surface of Streptococcus pneumoniae bacteria and was
found to be a novel S. pneumoniae vaccine candidate, illustrating that proteins
which are considered as cytosolic can be immunogenic [29].
Conclusions
In summary, the use of formalin-inactivated D. agamarum Ribi adjuvanted as well
as incomplete Freund’s adjuvanted vaccines result in seroconversion in lizards and
confer partial protection against D. agamarum associated disease. The latter
vaccine however, provokes the development of persistent granulomas following
subcutaneous administration. Proteome analysis of the antigens that bind with
sera from animals with seroconversion after Ribi vaccination reveals several
possible vaccine candidates such as fructose-bisphosphate aldolase and aldo-keto
reductase.
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